PPCB Propanc Biopharma, Inc.
Nasdaq · SEC CIK 1517681 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 3 since 2021-08-20, latest 2023-08-23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 2
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-20 | 2021-08-17 | PPCB | Kenyon Julian Norman | CSO, Dir | A - Grant | $0.00 | +3.42M | 3.42M | +68,400,000% | $0 | |
| MI | 2021-08-20 | 2021-08-17 | PPCB | Nathanielsz James Andrew | CEO, CFO, Dir | A - Grant | $0.00 | +8.73M | 2.80M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations